Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Members in the News

NOTE: News organizations may not keep articles permanently on their sites. As a result, links to news items that have expired may not work.

2016
  • January
    • Carol Lange, Ph.D., Cell Signaling Program leader, is featured in the story on mentoring in the lab - “Back to School” -  in Endocrine News. The story also features Lange’s most recent graduate and a former Cancer Biology Training Grant Predoctoral fellow, Caroline Diep, Ph.D. Read more on page 33.
    • The Masonic Cancer Center is mentioned in a Big Ten Cancer Research Consortium BTN LiveBIG story on cervical cancer, "Working to save lives from cervical cancer."
    • Pamala Jacobson, Pharm.D., Transplant Biology and Therapy Program, is quoted in a Minnesota Daily report on the discovery that an anti-immune drug can prevent the spread of cancer.
    • The Masonic Cancer Center was mentioned in a PRNewswire report on Oxis International, Inc. debt restructuring. The report notes that this will pave the way for moving forward with the Phase 1/Phase 2 FDA clinical trial in collaboration with the Masonic Cancer Center, University of Minnesota.
    • Timothy Church, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship program, will be on the advisory board of a new company that was formed by Illumina to enable early cancer detection via blood-based screening. Read more in Business WireGenetic, Engineering and Biotechnology News, PharmaBiz.
    • Research by Joseph Neglia, M.D., M.P.H., Screening, Prevention, Etiology and Cancer Survivorship program, was featured in Health News Digest. 
    • Business Wire and GEN announced that Illumina has formed a new company, GRAIL, to enable cancer screening from a simple blood test. GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids. Timothy Church, Ph.D.,  Screening, Prevention, Etiology and Cancer Survivorship Program, has been named to the new company’s advisory board.
    • The Masonic Cancer Center was mentioned in a BPLeader.com story about a cancer auction in Faribault that raises funds for the Eagles Cancer Telethon each January.  The telethon raises money for cancer research at Mayo Clinic, Hormel Institute for Cancer Research and the Masonic Cancer Center. This year’s telethon is scheduled for January 16-17.
    • Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, is quoted in a Student Science article about the World Health Organization report on the cancer risk associated with consumption of processed meats.
    • Business Wire and GEN announced that Illumina has formed a new company, GRAIL, to enable cancer screening from a simple blood test. GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids. Timothy Church, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship Program, has been named to the new company’s advisory board.
    • The Masonic Cancer Center was mentioned in a BPLeader.com story about a cancer auction in Faribault that raises funds for the Eagles Cancer Telethon each January. The telethon raises money for cancer research at Mayo Clinic, Hormel Institute for Cancer Research and the Masonic Cancer Center. This year’s telethon is scheduled for January 16-17.
    • Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, is quoted in a Student Science article about the World Health Organization report on the cancer risk associated with consumption of processed meats.
  • February
    • Logan Spector, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship Program, and Erin Marcotte, Ph.D., are quoted in a number of reports about a potential correlation between pre-labor cesarean delivery (PLCD) and acute lymphoblastic leukemia (ALL) could offer new targets for cancer prevention research, according to their study published in the current edition of the journal The Lancet Haematology. See Fox 9EurekAlert. Business Standard. Hindustan Times. News-Medical. UPI.
    • Jakub Tolar, M.D., Ph.D., Transplant Biology and Therapy Program, is featured in a video at UMN Health. View the video.
    • Douglass Yee, M.D., Masonic Cancer Center Director, is featured in a video at UMN Health. View the video.
    • Daniel Vallera, Ph.D., Tumor Microenvironment Program, was quoted in a PRN Newswire report announcing that Oxis Bioteching received a key patent ruling for its cancer drug OXS,1550, which was invented by Vallera.
    • John Wagner, M.D., co-leader, Transplant Biology and Therapy Program, was featured in news stories on WCCO and KSTP about Travis Moore, a patient he treated for leukemia as a child, who returned to the Twin Cities to visit patients and share his story.  Watch the WCCO videoWatch the KSTP video.
    • Bruce Walcheck, Ph.D., is featured in a Health Talk story about his research using natural killer cells to fight ovarian cancer.
    • Christopher Pennell, Ph.D., associate director of Education and Community Outreach, is featured in a Health Talk blog post about the White House’s “Cancer Moonshot.” Health Talk plans to produce a series dedicated to cancer research in honor of this campaign.
    • Hideki Aihara, Ph.D., Genetic Mechanisms of Cancer Program, is quoted in Star Tribune and Minnesota Daily reports on his laboratory’s research discovering clues to viral replication that could impact treatment of HIV and other cancers, was published in the journal Nature. The University of Minnesota’s Discover Health and Medicine blog also featured this report.
    • Research conducted by DeAnn Lazovich, Ph.D., M.P.H., is mentioned in a News 9 report that Oklahoma legislators are considering bills that would ban tanning bed use for anyone under 18. The research is also featured in the University of Arizona’s Daily Wildcat.
    • The Masonic Cancer Clinic is mentioned in a KARE 11 report about the new M Health Clinics and Surgery Center. View the video.
    • Pamala Jacobson, PharmD., is featured on the homepage of the University of Minnesota.
    • David Largaespada, Ph.D., Subbaya Subramanian, Ph.D., Jaime Modiano, D.V.M., Ph.D., and Branden Moriarity, Ph.D., Genetic Mechanisms of Cancer Program, and Brenda Weigel, M.D., Transplant Biology and Therapy Program, were mentioned and quoted in a Star Tribune front page story about the osteosarcoma research underway at the Masonic Cancer Center, University of Minnesota. The article notes that this work has received generous funding from the Zach Sobiech Osteosarcoma Fund, housed at the Children’s Cancer Research Fund. Crowdfunding has raised more than $1 million as of last fall from individuals inspired by Zach Sobiech’s story.
    • Christopher Moertel, M.D., Immunology Program, was quoted in a Fox9 news report about a fundraising run for the Children’s Tumor Foundation that will support neurofibromatosis (NF) research and treatment at the U of M, which is one of the top centers for NF research in the country.
    • Angela Panoskaltsis-Mortari, Ph.D., Transplant Biology and Therapy Program, was featured in a KARE11 TV’s “Next Big Thing” report about 3D printing.
    • Badrinath Konety, M.D., Associate Director of Clinical Affairs and Cell Signaling Program member, was quoted in a Business Wire report about his researcher showing that the 4Kscore test reduces unnecessary prostate biopsies while improving risk prediction for aggressive prostate cancer.
    • Research by DeAnn Lazovich, Ph.D., M.P.H., Screening, Prevention, Etiology and Cancer Survivorship Program, was featured in an Oncology Nurse Advisor. The research found that earlier and more frequent tanning bed use by women is associated with melanoma incidence and age at diagnosis.
    • DeAnn Lazovich, Ph.D., M.P.H., Screening, Prevention, Etiology and Cancer Survivorship program, was quoted in stories about her research showing indoor tanning can heighten melanoma risk sixfold. See Huffington Post, Regal Tribune,Lighthouse News Daily, Reuters, Latinos Health, Live Mint.
    • Ghautam Jha, M.D., is featured in a story of the Big Ten Cancer Research Consoritium’s website about a poster presentation at the 2016 Genitourinay Cancers Symposium in San Francisco, where he and other colleagues presented data on the Phase 1B portion of a clinical trial establishing the maximum tolerated dose of pembrolizumab and bevacizumab in combination for subjects with metastatic clear cell renal carcinoma after failure of at least one systemic therapy for metastatic disease.  The trial is now a Phase 2 ongoing trial. 
    • Louise Mansky, Ph.D., Genetic Mechanisms of Cancer Program is quoted in reports on his research identifying how drug target blocks HIV’s ability to spread.  Eureka Alert, Health Talk, Infection Control Today.
    • The Masonic Cancer Center joined other comprehensive NCI cancer centers to issue a joint statement supporting the HPV vaccine for cancer prevention. Peter Argenta, M.D., comments on the John Hines Show. WCCO Radio. Additional coverage of the statement: NewsweekFox News Health, Parent HeraldPulse Headlines, and MedPage Today. WCCO TV evening news reported on the statement the day it was issued as well.
    • Research by DeAnn Lazovich, Ph.D., M.P.H., showing that young women with melanoma tanned indoors earlier and more often was featured by CBS NewsU.S. News & World ReportBringMeTheNewsMedPage TodayEurekAlert!Medical XpressHealth Talk, Everyday Health,  Pulse HeadlinesCounsel and HealYahoo News, Cancer Network. Tech Times, Daily Mail, Univision Salud, Huffington Post,  Regal TribuneLighthouse News Daily. The research was published in the JAMA Dermatology.
    • Research conducted by Subbaya Subramanian, Ph.D., David Largaespada, Ph.D., Clifford Steer, M.D., and Jingmin Shu, Ph.D., Genetic Mechanisms of Cancer Program, was highlighted in EurekAlert, News-Medical. The study, published in the journal Oncotarget, showed that DNA imprinting defects are associated with childhood osteosarcoma development and progression.
  • March
    • Emil Lou, M.D., Ph.D., Tumor Microenvironment Program, provided an expert perspective in the AHC’s Health Talk on the latest research showing that using aspirin regularly may lower cancer risk.
    • Irina Stepanov, Ph.D., Carcinogenesis and Chemoprevention Program, was quoted in a Health Talk blog post on the development of a unique method to analyze oxidative DNA damage in age-related macular degeneration.
    • Todd Tuttle, M.D., Screening, Prevention, Etiology and Cancer Survivorship Program, commented in a WCVB-Boston report that the rate of double mastectomies has tripled over the past 10 years.
    • Several Masonic Cancer Center were featured in a BTCRC Colorectal Cancer Awareness Month story.
      Ran Blekhman, Ph.D., Genetic Mechanisms of Cancer Program, was featured in the BTCRC newsletter for his research published in Genome Medicine that found a gut microbiome that could be linked to colon cancer.
      Aasma Shaukat, M.D., M.P.H., Screening, Cancer Prevention, Etiology and Survivorship Program, was quoted about her research finding that longer colonoscopies result in fewer colon cancers.
      Tim Starr, Ph.D., Robert Cormier, Ph.D., and David Largaespada, Ph.D., Genetic Mechanisms of Cancer Program, found that a gene that causes cystic fibrosis also causes colon cancer
    • The research of Subbaya Subramanian, Ph.D., Genetic Mechanisms of Cancer Program, showing that children with osteosarcoma may be impacted by DNA imprinting was highlighted in the Across the Consortium column in the Big Ten Cancer Research Consortium’s (BTCRC) March e-newsletter.
    • Todd Tuttle, M.D., Screening, Prevention, Etiology and Cancer Survivorship Program, is quoted in a Bring Me The News report on the increases in double mastectomies for women in have cancer in one breast, without evidence that they improve survival rates.
    • Erin Marcotte, Ph.D., was featured in an interview in Medical Research.com discussing research showing a relationship between cesarean section births and the risk of childhood leukemia.
    • Douglas Yee, M.D., Director, Masonic Cancer Center, was interviewed in an MHealth news story about the improvements in treatment options for women diagnosed with breast cancer while pregnant. Read more.
    • Erin Dickerson, Ph.D., Amy Skubitz, Ph.D., Tumor Microenvironment Program members, and Subree Subramaniam, Ph.D., Genetic Mechanisms of Cancer Program member, are featured in the March Rein in Sarcoma Update and website as recipients of the 2016-2017 Karen Wyckoff Rein in Sarcoma Foundation’s Cancer Fellowships. Read more.
    • Thomas Griffith, Ph.D., Immunology Program, is quoted in a Naturereport on a pioneering apoptosis-targeted drug poised for FDA approval.
    • Erin Marcotte, Ph.D., is featured in a Medical Research interview about her research showing that cesarean delivery may increase risk for childhood leukemia. 
  • April
    • Anne Blaes, M.D., Screening Prevention, Etiology and Cancer Surivorship Program, and Ruth Bachman, Chair, Masonic Cancer Center Community Advisory Board, were interviewed for a WCCO TV story about the Cancer Suvivorship Conference held Saturday at the University of Minnesota. View the video.
    • Stephen Jameson, Ph.D., and David Masopust, Ph.D., Immunology Program, were quoted in a ScienceDaily report on a paper they published online in the journal Nature, demonstrating a new way to study mice that better mimics the immune system of adult humans, which could significantly improve potential therapeutics. This was also reported in Science Magazine, The Economist, Nature, The Scientist, Cosmos, and The Ledger Independent.
    • Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, was quoted in a story about recommendations for health grilling in the May issue of Dr. Oz The Good Lifemagazine.
    • Anne Joseph, M.D., M.P.H., and Carol Lange, Ph.D., were featured in a Medical Bulletin article on plans for addressing the lack of women in leadership roles in the University of Minnesota Medical School. Joseph and Lange are co-chairing the Committee on Women in Leadership. 
    • Zigang Dong, M.D., Dr.P.H., and Ann Bode, Ph.D., were quoted in a press release announcing a new open access journal, npj Precision Oncology in About npg.com. The new journal is a joint venture by Springer Nature and the Hormel Institute. Dong and Bode are members of the Carcinogenesis and Chemoprevention Program.
    • Research conducted by Irina Stepanov, Ph.D., Sharon E. Murphy, Ph.D., Steven G. Carmella, B.A., Heather H. Nelson, Ph.D., Dorothy Hatsukami, Ph.D., and Stephen S. Hecht, Ph.D., in collaboration with Jian-Min Yuan, M.D., Ph.D. at the University of Pittsburgh Cancer Institute, was featured in Science Daily report. The research on watercress extract’s ability to inhibit activation of tobacco-derived carcinogens, was presented at the recent meeting of the American Society for Cancer Research in New Orleans.
    • Perry Hackett, Ph.D., and Peter Bitterman, M.D., Genetic Mechanisms of Cancer Program, Troy Lund, M.D., Ph.D., Transplant Biology and Therapy Program, and Carston Wagner, Ph.D., Carcinogenesis and Chemoprevention Program, were mentioned in a Medical Bulletin story about zebrafish.
    • The Masonic Cancer Center’s 25th anniversary was featured in the latest issue of the Medical Bulletin.
    •  Nelson Rhodus, D.M.D., M.P.H., is mentioned in a Brainerd Dispatch story on a Minnesota Sparks event in Brainerd. The event is part of a larger series of forums throughout Minnesota that feature University of Minnesota researchers. Rhodus discussed how diseases such as cancer, diabetes and leukemia often first manifest in the mouth.
    • The Masonic Cancer Center was mentioned in a KARE 11 story about Concert for a Cure, an event featuring four high school bands held at Hastings High School on April 13 to raise money for the center.
    • Jakub Tolar, M.D., Ph.D., Transplant Biology and Therapy Program, was quoted in an Albany Daily Star report on the development of a 3-D printing method to make embryonic stem cells.
    • Alicia Kunin-Baston, Ph.D., Screening, Prevention, Etiology and Cancer Suvivorship Program, was quoted in a HemOnc Today report on research she published in the journal Cancer showing that emotional stress is prevalent in children with acute lymphoblastic leukemia during and after treatment.
    • The Masonic Cancer Center is mentioned in a Buffalo Business First report about the NIH’s National Institute on Drug Abuse (NIDA) Population Assessment of Tobacco and Health (PATH) study. Roswell Park Cancer Institute is the lead investigator and the Masonic Cancer Center is a scientific partner, sharing in the $17.7 million award, with Stephen Hecht, Ph.D., and Dorothy Hatsukami, Ph.D., as co-principal investigators. The study will provide NIDA and the Food and Drug Administration with the data to support population-based tobacco regulations to reduce the disease burden caused by tobacco.
    • The Masonic Cancer Center was featured and Kiara Ellis, Education and Community Engagement Manager, was interviewed in a KARE11 TV story about Scrubs Camp for Minneapolis students on spring break. The students met in the Cancer and Cardiovascular building and heard presentations by MCC members and staff Rita Bouley, R.N., Christopher Pennell, Ph.D., and Irina Stepanov, Ph.D.
    • Reuben Harris, Ph.D., Genetic Mechanisms of Cancer Program, was mentioned in a Science.Mic report on the latest treatment breakthrough for HIV and AIDS.
    • Badrinath Konety, M.D., Associate Director of Clinical Affairs for the Masonic Cancer Center, was featured in a Minnesota Public Radio program about the Center for Healthy African American Men through Partnerships forum "Reducing Violence against African-American Males."
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on April 27, 2016